The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity.

Its scope is:

arrow Interaction with authorities regarding immunogenicity guidelines

arrow Formulate active recommendations regarding immunogenicity

arrow Stimulate research addressing the clinical and non-clinical effects of unwanted immunogenicity

arrowCollaboration between academia and pharmaceutical companies,

The European Immunogenicity Platform aims to build a broad knowledge-base related to immunogenicity, and to stimulate interactions and developments in the broad field of immunogenicity.

Through its working-group structure, the EIP can react in a focused way on regulatory and scientific evolutions in the immunogenicity-field. The European Immunogenicity Platform was created early 2007 by experts in the field of immunogenicity.

Program of the 2016 conference will be published end of October 2015.


More information available herearrow_yellow